
Discussing Lupus: July 2026
Professor Christopher Edwards and Professor Chi-Chiu Mok discuss two recent studies advancing the treatment landscape in SLE. This episode discusses the safety of belimumab during pregnancy and the 2026 British Society f

Loading…
Hosted by Unknown Host · 🇺🇸 US · EN · 100 episodes
Established thought leaders with verified media credentials.
Welcome to the Lupus Forum. The Lupus Forum is an educational website developed under the auspices of the University of Leeds and is dedicated to the dissemination of the latest developments in the field of lupus. It provides continuing medical education to clinicians around the globe to facilitate greater understanding of lupus, its treatments, and clinical practice.
Unknown Host hosts The Lupus Forum, a education show with 100 episodes published.

Professor Christopher Edwards and Professor Chi-Chiu Mok discuss two recent studies advancing the treatment landscape in SLE. This episode discusses the safety of belimumab during pregnancy and the 2026 British Society f

Tune into this episode of our 'Guiding Lupus Clinical Management' podcast series and hear from Professors Ed Vital, Maria Dall'Era and Guillermo Pons-Estel as they discuss ACR and EULAR guidance on hematological manifest

Join Ed Vital, from the University of Leeds, United Kingdom, and Marc Scherlinger, from Strasbourg University Hospital, as they discuss his recent paper ‘Relapse risk of lupus-related serositis according to immunosuppres

Dr Guillermo J. Pons-Estel and Professor Victoria Werth highlight the latest advances in lupus treatment. This podcast discusses the efficacy and safety of dapirolizumab pegol in patients with systemic lupus erythematosu

Tune into this episode of our 'Guiding Lupus Clinical Management' podcast series and hear from Professors Ed Vital and Maria Dall'Era as they take a closer look at the ACR and EULAR guideline development models and consi

Professor Ed Vital and Professor Chris Edwards discuss two recent studies advancing the treatment landscape in SLE. This episode discusses real-world effectiveness of anifrolumab in moderate-to-severe SLE and belimumab i

Join Professor Ed Vital as he reviews his highlights from the recent EULAR 2026 congress and discusses key abstracts and findings.

Join Professor Chris Edwards as he summarises his top lupus abstracts, posters, and presentations for Day 4 of EULAR 2026 (Saturday, June 6th).

Join Professor Chris Edwards as he summarises his top lupus abstracts, posters, and presentations for Day 3 of EULAR 2026 (Friday, June 5th).

Join Professor Chris Edwards as he summarises his top lupus abstracts, posters, and presentations for Day 2 of EULAR 2026 (Thursday, June 4th).

Join Professor Chris Edwards as he summarises his top lupus abstracts, posters, and presentations for Day 1 of EULAR 2026 (Wednesday, June 3rd).

Join Professor Chris Edwards as he previews what we are most looking forward to this EULAR, introducing some of the top abstracts and posters we’ve chosen so that you can better plan your time at what will be a busy and

Professor Eric Morand and Doctor Kathryn Connelly discuss two recent studies advancing the treatment landscape in SLE and lupus nephritis. This episode discusses antimalarial use and extra-renal damage accrual in lupus n

Tune into this episode of our 'Guiding lupus clinical management' podcast series and hear from Professors Ed Vital, Liz Lightstone and Brad Rovin as they discuss ACR and EULAR guidance on renal manifestations of lupus an

Professor Ed Vital and Professor Chris Edwards discuss two recent studies advancing the treatment landscape in SLE. This episode discusses S1PR1-mediated modulation of immune cell trafficking as a potential upstream ther

Professor Victoria Werth and Professor Chi-Chiu Mok discuss two recent studies advancing the treatment landscape in SLE and lupus nephritis. This episode reviews findings from the Phase 2 TULIP-LN trial, highlighting how

Professor Victoria Werth and Doctor Guillermo J. Pons-Estel highlights the new treatment safety and efficacy and impact of mental health outcomes in SLE. This podcast discusses efficacy and safety of SC anifrolumab in SL

Professor Ed Vital discusses two key publications covered on the Lupus Forum in December. his podcast reviews data from a randomised, double-blind, placebo-controlled Phase Ib/IIa trial of the anti-CD38 monoclonal antibo

Professor Richard Furie and Doctor Guillermo J. Pons-Estel review two key publications covered on the Lupus Forum in November. This podcast reports data from a multicentre, randomised, double-blind, placebo-controlled tr

Professor Vibeke Strand highlights the emerging treatments in SLE and LN. This podcast reports the efficacy and safety results of a Phase 3 trial of telitacicept at a dose of 160mg weekly as compared with PBO in Chinese
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.






The Lupus Forum has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their education audience.
The Lupus Forum is hosted by Unknown Host. The show is categorised under education and has published 100 episodes.
The Lupus Forum has published 100 episodes.
The Lupus Forum regularly covers education. It sits in the education category.
The Lupus Forum is accessible for guests with genuine education expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
The Lupus Forum hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of The Lupus Forum average 19 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates The Lupus Forum's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 6 days ago.